Avid Bioservices Inc (CDMO)

[cjgaddy]

Just like on 7-14-16 the morning of the Q4/CC, you “predicted” $12mm for Q4, after Peregrine had PR’d on 6-2-16 that FY’16 revs would be $44mm, meaning Q4 had to be at least $18.4mm. Turned out they were $18.8mm. Not another word about that, you moved onto your Rob Garnick is gone assertion, and then etc etc etc.

“I will go with $39mm and $12mm.”
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=123864929

9-8-16/CC/P.Lytle: “We now expect to recognize revenue in excess of $20mm in Q2/FY2017. I would also like to reaffirm our full FY2017 revenue guidance of $50-55mm, representing up to 24% and yr-over-yr growth compared to last FY. And it's important to note that our projected revenue growth is supported by current revenue backlog of $71mm under signed contacts covering services to be completed during the remainder of FY17 and into FY18.” http://tinyurl.com/jydtkoy